Skip to content

REGENERX BIOPHARMACEUTICALS, INC.: filings

Every REGENERX BIOPHARMACEUTICALS, INC. annual and quarterly report in the SEC record with the published financial measures it tagged, 48 filings, each linked to its SEC index.

Filing record ends 2023-05-15

The latest filing in this captured record is a 10-Q filed 2023-05-15. No later filing is in the SEC companyfacts record captured on 2026-09-22. REGENERX BIOPHARMACEUTICALS, INC. may have stopped filing, merged, or changed its reporting entity; nothing on this page describes its current status. Values are as reported at the time.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2023-05-15fiscal Q1 202332690001410578-23-001223
10-K2023-04-11fiscal FY 202238780001410578-23-000628
10-Q2022-11-14fiscal Q3 2022341060001410578-22-003350
10-Q2022-08-12fiscal Q2 2022341030001410578-22-002406
10-Q2022-05-16fiscal Q1 202234710001410578-22-001705
10-K2022-03-30fiscal FY 202138780001104659-22-040167
10-Q2021-11-15fiscal Q3 2021341080001104659-21-139207
10-Q2021-08-06fiscal Q2 2021341030001104659-21-101442
10-Q2021-05-14fiscal Q1 202134710001104659-21-066826
10-K2021-03-02fiscal FY 202040850001104659-21-030728
10-Q2020-11-13fiscal Q3 2020361130001104659-20-125049
10-Q2020-08-14fiscal Q2 2020361080001104659-20-095495
10-Q2020-05-15fiscal Q1 202036750001104659-20-062170
10-K2020-03-20fiscal FY 201942870001104659-20-036901
10-Q2019-11-14fiscal Q3 2019371170001104659-19-064155
10-Q2019-08-14fiscal Q2 2019361110001144204-19-040034
10-Q2019-05-15fiscal Q1 201936770001144204-19-026538
10-K2019-03-29fiscal FY 201837760001144204-19-016982
10-Q2018-11-14fiscal Q3 201831860001144204-18-059911
10-Q2018-08-09fiscal Q2 201831860001144204-18-043273
10-Q2018-05-15fiscal Q1 201831640001144204-18-028835
10-K2018-03-29fiscal FY 201738770001144204-18-017995
10-Q2017-11-14fiscal Q3 201730840001144204-17-058996
10-Q2017-08-21fiscal Q2 201728800001144204-17-044397
10-Q2017-05-15fiscal Q1 201728580001144204-17-027481
10-K2017-03-29fiscal FY 201633670001144204-17-017360
10-Q2016-11-14fiscal Q3 201628750001144204-16-134301
10-Q2016-08-22fiscal Q2 201628750001144204-16-120551
10-Q2016-05-16fiscal Q1 201624500001144204-16-102576
10-K2016-04-11fiscal FY 201528580001144204-16-093682
10-Q2015-11-13fiscal Q3 201529820001144204-15-065334
10-Q2015-08-14fiscal Q2 201525660001144204-15-049933
10-Q2015-05-15fiscal Q1 201524500001144204-15-031410
10-K2015-03-31fiscal FY 201429590001144204-15-020097
10-Q2014-11-10fiscal Q3 201430820001144204-14-066195
10-Q2014-08-14fiscal Q2 201425650001144204-14-050177
10-Q2014-05-15fiscal Q1 201427560001144204-14-031307
10-K2014-04-04fiscal FY 201330620001144204-14-020919
10-Q2013-11-18fiscal Q3 201327680001144204-13-062686
10-Q2013-08-14fiscal Q2 201327680001144204-13-045815
10-Q2013-05-15fiscal Q1 201327560001144204-13-029558
10-K2013-04-16fiscal FY 201232660001144204-13-022111
10-Q2012-11-14fiscal Q3 201229700001144204-12-062514
10-Q2012-08-14fiscal Q2 201228680001144204-12-045623
10-Q2012-05-15fiscal Q1 201229560001193125-12-234877
10-K2012-04-04fiscal FY 201129600001193125-12-150122
10-Q2011-11-14fiscal Q3 201128680000950123-11-098532
10-Q2011-08-05fiscal Q2 201128660000950123-11-073148

Inspect the source

Entity
REGENERX BIOPHARMACEUTICALS, INC. / CIK 0000707511
Captured
SEC response SHA-256
ffc4eb5988984f6f0271e31d8cf8024b0343b848cad3a73089a36cab28954e4d

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000707511.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))